Thus, our data evidence important roles of GPT2 in airway epithelial lipid reprogramming after smoking and molecular mechanisms of GPT2‐dominated regulation, which can be an alternative to therapeutic strategies for chronic lung diseases. This evidence concerns the gene GPT2 and chronic lung disease.